arginine has been researched along with Bone Loss, Osteoclastic in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 7 (43.75) | 29.6817 |
| 2010's | 3 (18.75) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Onuora, S | 1 |
| Ikegami, S; Kato, H; Nakamura, Y; Nakano, M; Sakai, N; Suzuki, T; Takahashi, J; Tokida, R; Uehara, M | 1 |
| Carballo, J; Delgado-Andrade, C; Navarro, MP; Roncero-Ramos, I; Rufián-Henares, JÁ | 1 |
| Choi, SW; Kim, SH; Yeon, JT | 1 |
| Bollerslev, J; Dziegiel, MH; Gram, J; Henriksen, K; Jensen, VK; Karsdal, MA; Neutzsky-Wulff, AV | 1 |
| Saito, M | 1 |
| Dong, XN; Qin, A; Wang, X; Xu, J | 1 |
| Franke, S; Hein, G; Lehmann, G; Stein, G; Wiegand, R | 1 |
| Agata, N; Ebihara, T; Kawai, T; Lin, CY; Mukherjee, PM; Olsen, BR; Onji, M; Reichenberger, E; Saheki, Y; Senoo, M; Ueki, Y | 1 |
| Lipman, ML; Mann, JF; Schiffrin, EL | 1 |
| Takeuchi, Y | 1 |
| Komatsubara, S; Marumo, K; Mashiba, T; Mori, S; Saito, M | 1 |
| Benjamin, N; Grabowski, PS; Helfrich, MH; Ho, LP; Johnston, PW; Ralston, SH | 1 |
| Löwik, CW; Nibbering, PH; Papapoulos, SE; van de Ruit, M | 1 |
| Aimaretti, G; Cerbone, G; Colao, A; Corneli, G; Di Somma, C; Faggiano, A; Ghigo, E; Loche, S; Lombardi, G; Pivonello, R | 1 |
| Amirhakimi, GH; Bryson, MF; Forbes, GB; Reina, JC | 1 |
3 review(s) available for arginine and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
[Biochemical markers of bone turnover. New aspect. Bone collagen metabolism: new biological markers for estimation of bone quality].
Topics: Arginine; Biomarkers; Bone and Bones; Bone Density; Bone Remodeling; Bone Resorption; Collagen; Glycation End Products, Advanced; Homocysteine; Humans; Lysine; Osteoporosis; Oxidative Stress | 2009 |
Chronic kidney disease: effects on the cardiovascular system.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Atherosclerosis; Biomarkers; Bone Resorption; Calcinosis; Calcium; Cardiovascular Diseases; Chronic Disease; Clinical Trials as Topic; Cohort Studies; Creatinine; Cystatin C; Cystatins; Diabetes Complications; Disease Progression; Dogs; Dyslipidemias; Endothelium, Vascular; Glomerular Filtration Rate; Humans; Hypertension, Renal; Inflammation Mediators; Kidney Diseases; Oxidative Stress; Phosphates; Renin-Angiotensin System; Risk Factors | 2007 |
[Assessment of bone quality with metabolic bone markers].
Topics: Alkaline Phosphatase; Amino Acids; Arginine; Biomarkers; Bone and Bones; Bone Resorption; Collagen Type I; Forecasting; Fractures, Bone; Homocysteine; Humans; Lysine; Osteocalcin; Osteogenesis; Peptides; Tensile Strength | 2007 |
1 trial(s) available for arginine and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism.
Topics: Adolescent; Adult; Aged; Arginine; Bone Density; Bone Resorption; Female; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Hypopituitarism; Insulin-Like Growth Factor I; Male; Middle Aged | 1999 |
12 other study(ies) available for arginine and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
L-arginine inhibits arthritis and bone loss by reprogramming osteoclast metabolism.
Topics: Arginine; Arthritis; Bone Resorption; Cell Differentiation; Humans; Osteoclasts; RANK Ligand | 2023 |
Reference values for bone metabolism in a Japanese cohort survey randomly sampled from a basic elderly resident registry.
Topics: Aged; Aged, 80 and over; Aging; Alkaline Phosphatase; Arginine; Biomarkers; Bone Density; Bone Resorption; Cohort Studies; Female; Femur Neck; Hip; Humans; Japan; Lysine; Male; Middle Aged; Osteoporosis; Reference Values; Registries; Tartrate-Resistant Acid Phosphatase; Vitamin D | 2021 |
Effects of model Maillard compounds on bone characteristics and functionality.
Topics: Animals; Arginine; Biomarkers; Biomechanical Phenomena; Bone and Bones; Bone Resorption; Collagen Type I; Female; Glucose; Glycation End Products, Advanced; Lysine; Maillard Reaction; Rats; Rats, Wistar | 2013 |
Arginase 1 is a negative regulator of osteoclast differentiation.
Topics: Animals; Arginase; Arginine; Bone Marrow Cells; Bone Resorption; Cell Differentiation; Cells, Cultured; Down-Regulation; Hematopoiesis; Macrophages; Male; Mice; Mice, Inbred ICR; Nitric Oxide; Ornithine; Osteoclasts; RANK Ligand; RNA Interference; RNA, Small Interfering; Signal Transduction | 2016 |
Characterization of acid flux in osteoclasts from patients harboring a G215R mutation in ClC-7.
Topics: Acids; Arginine; Bone Resorption; Calcium; Chloride Channels; Genes, Dominant; Glycine; Humans; Hydrogen-Ion Concentration; Lysosomes; Mutation; Osteoclasts; Vacuolar Proton-Translocating ATPases | 2009 |
In situ accumulation of advanced glycation endproducts (AGEs) in bone matrix and its correlation with osteoclastic bone resorption.
Topics: Adult; Age Factors; Aged; Arginine; Bone Matrix; Bone Resorption; Chromatography, High Pressure Liquid; Glycation End Products, Advanced; Humans; Immunohistochemistry; Lysine; Microscopy, Fluorescence; Middle Aged; Osteoclasts | 2011 |
Advanced glycation end-products pentosidine and N epsilon-carboxymethyllysine are elevated in serum of patients with osteoporosis.
Topics: Adult; Aged; Analysis of Variance; Arginine; Bone Resorption; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Osteoporosis | 2003 |
Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 "cherubism" mice.
Topics: Adaptor Proteins, Signal Transducing; Animals; Arginine; Bone Marrow Cells; Bone Resorption; CD11b Antigen; Cell Differentiation; Cherubism; Disease Models, Animal; Hematologic Diseases; Homozygote; Inflammation; Intracellular Signaling Peptides and Proteins; Lymph Nodes; Macrophage Colony-Stimulating Factor; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mutation; Myeloid Cells; Osteoclasts; Phosphorylation; Proline; Protein-Tyrosine Kinases; RANK Ligand; Spleen; Syk Kinase; Tumor Necrosis Factor-alpha | 2007 |
Collagen maturity, glycation induced-pentosidine, and mineralization are increased following 3-year treatment with incadronate in dogs.
Topics: Animals; Arginine; Biomechanical Phenomena; Bone Density Conservation Agents; Bone Resorption; Calcification, Physiologic; Calcium; Collagen; Diphosphonates; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Glycation End Products, Advanced; Lysine; Male; Phosphorus; Ribs | 2008 |
Nitric oxide: a cytokine-induced regulator of bone resorption.
Topics: Animals; Arginine; Base Sequence; Bone Resorption; Calcium; Cytokines; Dinoprostone; DNA Primers; Drug Synergism; Enzyme Inhibitors; Humans; Interferon-gamma; Interleukin-1; Mice; Molecular Sequence Data; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Organ Culture Techniques; Osteoclasts; Penicillamine; Polymerase Chain Reaction; Recombinant Proteins; RNA; S-Nitroso-N-Acetylpenicillamine; Tumor Necrosis Factor-alpha | 1995 |
Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption.
Topics: Animals; Arginine; Bone Resorption; Cells, Cultured; Female; Interferon-gamma; Interleukin-1; Lipopolysaccharides; Mice; Nitric Oxide; omega-N-Methylarginine; Osteoblasts; Osteoclasts; Pregnancy; Tumor Necrosis Factor-alpha | 1994 |
Metabolic response to growth hormone administration, with particular reference to the occurrence of hypercalcuria.
Topics: Adolescent; Arginine; Basal Metabolism; Bone Resorption; Calcium; Child; Child, Preschool; Creatinine; Electrolytes; Feces; Fluorides; Growth Disorders; Growth Hormone; Humans; Hydroxyproline; Hypoparathyroidism; Insulin; Lead; Magnesium; Middle Aged; Phosphorus; Potassium; Strontium | 1972 |